Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rockwell Medical Inc (NASDAQ:RMTI)

8.05
Delayed Data
As of 3:59pm ET
 -0.05 / -0.62%
Today’s Change
5.47
Today|||52-Week Range
15.88
-21.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$417.4M

Company Description

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the targeting of end-stage renal disease and chronic kidney disease and manufactures innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.

Contact Information

Rockwell Medical, Inc.
30142 Wixom Road
Wixom Michigan 48393
P:(248) 960-9009
Investor Relations:

Employees

Shareholders

Other institutional24.02%
Individual stakeholders11.99%
Mutual fund holders10.38%

Top Executives

Robert L. ChioiniChairman, President & Chief Executive Officer
Thomas E. KlemaCFO, Secretary, Treasurer & Vice President-Finance
Ajay GuptaChief Scientific Officer
Raymond D. PrattChief Medical Officer